Neural circuit regulation of systemic immunity via vagal neurons: Columbia Nature publication underpinning Nilo Therapeutics
Summary
Charles Zuker's laboratory at Columbia University published research in Nature identifying specific vagal neurons that regulate systemic immune activation and inflammation — the "master regulator" brain-body circuit that forms the scientific foundation for Nilo Therapeutics' $101M Series A. The paper characterizes the specific neuronal populations in the vagus nerve that interface between the central nervous system and peripheral immune compartments, showing that targeted activation or inhibition of these neurons modulates systemic inflammatory responses without the global immunosuppression of conventional drugs.
Why it matters
Zuker's Nature paper on vagal immune regulation is the foundational science behind one of the most ambitiously funded neuroimmunology companies in history. Publication of the specific neuronal identity and circuit-level mechanism provides the biological precision that distinguishes Nilo from the broader vagus nerve stimulation field — rather than broadly stimulating the vagus nerve, Nilo targets the specific subpopulations that regulate immunity, enabling far more precise therapeutic intervention.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial